BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 12, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Adipothermics, Inc. preclinical data

Researchers at Scripps Florida and the Dana-Farber Cancer Institute reported that a non-agonist PPAR gamma targeted compound significantly improve insulin sensitivity vs. vehicle-treated controls in mouse models of Type II...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >